FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029744511> ?p ?o ?g. }

• W2029744511 endingPage "88" @default.
• W2029744511 startingPage "81" @default.
• W2029744511 abstract "Treatment with a β-adrenergic blocker (β-blocker) in hypertension is associated with increased plasma atrial natriuretic peptide (ANP) levels despite a decrease in cardiac overload. The mechanism and pathophysiological significance of the phenomenon remain unclear. To clarify the role of the ANP system in the antihypertensive effects of the β-blocker, we investigated the effects of carvedilol (30 mg/kg·day, orally, for 4 weeks) on the ANP system in stroke-prone spontaneously hypertensive rats (SHR-SP/Izm). Plasma ANP levels showed a significant increase despite a significant decrease in blood pressure and heart rate in the carvedilol group. Although ANP messenger RNA levels in the heart did not change, messenger RNA levels of the natriuretic peptide-C (NP-C) receptor as a clearance receptor showed a significant decrease in both the aorta and lung in the carvedilol group. NP-C receptor densities were also significantly decreased in the lung in this group. The biological half-life of exogenous ANP in circulating blood was prolonged in the carvedilol group compared with that in the control group. Administration of the ANP receptor antagonist, HS-142–1, resulted in a greater increase in systolic blood pressure in the carvedilol group than in the control group. In addition, both basal and ANP-stimulated cGMP contents in the aorta were significantly higher in the carvedilol group. These results suggest that carvedilol potentiates the hypotensive action of ANP by increasing plasma ANP levels and enhancing the vascular response to ANP. These effects were closely related to the down-regulation of the NP-C receptor. The newly found mechanism seems to account for a sizable portion of the antihypertensive effects of carvedilol and could be of potential importance in the treatment of cardiovascular disease withβ -blockers." @default.
• W2029744511 created "2016-06-24" @default.
• W2029744511 creator A5011105044 @default.
• W2029744511 creator A5017193469 @default.
• W2029744511 creator A5030293363 @default.
• W2029744511 creator A5041743524 @default.
• W2029744511 creator A5046482075 @default.
• W2029744511 creator A5059254858 @default.
• W2029744511 creator A5065053580 @default.
• W2029744511 creator A5075757845 @default.
• W2029744511 creator A5090348913 @default.
• W2029744511 date "1998-01-01" @default.
• W2029744511 modified "2023-09-27" @default.
• W2029744511 title "Potentiation of Natriuretic Peptide Action by the β -Adrenergic Blocker Carvedilol in Hypertensive Rats: A New Antihypertensive Mechanism1" @default.
• W2029744511 cites W1162230242 @default.
• W2029744511 cites W1529645367 @default.
• W2029744511 cites W1540751296 @default.
• W2029744511 cites W1542279315 @default.
• W2029744511 cites W1570851270 @default.
• W2029744511 cites W1593231964 @default.
• W2029744511 cites W1606294561 @default.
• W2029744511 cites W1977609966 @default.
• W2029744511 cites W1979399597 @default.
• W2029744511 cites W1984853373 @default.
• W2029744511 cites W1984995072 @default.
• W2029744511 cites W2001875144 @default.
• W2029744511 cites W2004665183 @default.
• W2029744511 cites W2007281605 @default.
• W2029744511 cites W2008850968 @default.
• W2029744511 cites W2011113889 @default.
• W2029744511 cites W2012849996 @default.
• W2029744511 cites W2013130322 @default.
• W2029744511 cites W2013334996 @default.
• W2029744511 cites W2034152941 @default.
• W2029744511 cites W2038305939 @default.
• W2029744511 cites W2043492462 @default.
• W2029744511 cites W2046333786 @default.
• W2029744511 cites W2047004363 @default.
• W2029744511 cites W2048365121 @default.
• W2029744511 cites W2054649519 @default.
• W2029744511 cites W2056851052 @default.
• W2029744511 cites W2063400688 @default.
• W2029744511 cites W2064365475 @default.
• W2029744511 cites W2065531704 @default.
• W2029744511 cites W2067789062 @default.
• W2029744511 cites W2069256497 @default.
• W2029744511 cites W2070996706 @default.
• W2029744511 cites W2071457715 @default.
• W2029744511 cites W2081511516 @default.
• W2029744511 cites W2088440519 @default.
• W2029744511 cites W2090850356 @default.
• W2029744511 cites W2101415023 @default.
• W2029744511 cites W2106012825 @default.
• W2029744511 cites W2119455028 @default.
• W2029744511 cites W2119978550 @default.
• W2029744511 cites W2131120290 @default.
• W2029744511 cites W2134812217 @default.
• W2029744511 cites W2138391109 @default.
• W2029744511 cites W2141935051 @default.
• W2029744511 cites W2145117388 @default.
• W2029744511 cites W2157246974 @default.
• W2029744511 cites W2162631677 @default.
• W2029744511 cites W2326508838 @default.
• W2029744511 cites W2405603692 @default.
• W2029744511 cites W2412628192 @default.
• W2029744511 cites W571870702 @default.
• W2029744511 cites W83986006 @default.
• W2029744511 cites W2059823052 @default.
• W2029744511 doi "https://doi.org/10.1210/endo.139.1.5644" @default.
• W2029744511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9421401" @default.
• W2029744511 hasPublicationYear "1998" @default.
• W2029744511 type Work @default.
• W2029744511 sameAs 2029744511 @default.
• W2029744511 citedByCount "35" @default.
• W2029744511 countsByYear W20297445112014 @default.
• W2029744511 countsByYear W20297445112016 @default.
• W2029744511 countsByYear W20297445112017 @default.
• W2029744511 crossrefType "journal-article" @default.
• W2029744511 hasAuthorship W2029744511A5011105044 @default.
• W2029744511 hasAuthorship W2029744511A5017193469 @default.
• W2029744511 hasAuthorship W2029744511A5030293363 @default.
• W2029744511 hasAuthorship W2029744511A5041743524 @default.
• W2029744511 hasAuthorship W2029744511A5046482075 @default.
• W2029744511 hasAuthorship W2029744511A5059254858 @default.
• W2029744511 hasAuthorship W2029744511A5065053580 @default.
• W2029744511 hasAuthorship W2029744511A5075757845 @default.
• W2029744511 hasAuthorship W2029744511A5090348913 @default.
• W2029744511 hasBestOaLocation W20297445111 @default.
• W2029744511 hasConcept C126322002 @default.
• W2029744511 hasConcept C134018914 @default.
• W2029744511 hasConcept C170493617 @default.
• W2029744511 hasConcept C2775846464 @default.
• W2029744511 hasConcept C2778069365 @default.
• W2029744511 hasConcept C2778198053 @default.
• W2029744511 hasConcept C2780591200 @default.
• W2029744511 hasConcept C71924100 @default.
• W2029744511 hasConcept C84393581 @default.
• W2029744511 hasConceptScore W2029744511C126322002 @default.

• next